Romosozumab after rebound vertebral fractures induced by denosumab discontinuation: a case series

Although limited by the uncontrolled design and small sample size, these observations suggest that romosozumab might be considered as a potential therapeutic approach for selected patients with post-denosumab rebound fractures.

Institutions

Publication Details

Journal
JBMR Plus
Published
2025-12-06
DOI
https://doi.org/10.1093/jbmrpl/ziaf186
Primary Topic
Bone health and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Romosozumab after rebound vertebral fractures induced by denosumab discontinuation: a case series

JBMR Plus
Bone health and treatments
article

Romosozumab after rebound vertebral fractures induced by denosumab discontinuation: a case series

article en

Abstract

Although limited by the uncontrolled design and small sample size, these observations suggest that romosozumab might be considered as a potential therapeutic approach for selected patients with post-denosumab rebound fractures.

JBMR PlusVol. 10(2)
Universidad del Salvador (AR), Hospital Fernández (AR), Instituto de Diagnóstico e Investigaciones Metabólicas (AR)
Openalex Percentile: Top 34%
Bone health and treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Romosozumab after rebound vertebral fractures induced by denosumab discontinuation: a case series · JBMR Plus (2025) | TGRS Research Map | TGRS